This is the 8th year for the International Symposium on Ventricular Arrhythmias: Pathophysiology and Therapy. Using a combination of didactic presentations, panel discussions, and questions and answer sessions, our goal is to educate the participants on state-of-the-art information pertaining to the pathophysiology and treatment of ventricular arrhythmias. There will also be VT related cases streamed live from the University of Pennsylvania during which a moderated panel discussion and question and answer session will occur to educate and demonstrate to the audience members the most up to date techniques for complex ablation and other procedures.

A new study shows that atrial fibrillation (AF) increases the risk of dementia in older adults who have not had a stroke and have normal baseline cognitive function. The meta-analysis, published in the November edition of HeartRhythm,the official journal of the Heart Rhythm Society, is the first-of-its-kind to observe a large population of patients over a relatively long follow-up period. The study results support an independent longitudinal relationship between the two conditions, therefore associating the presence of AF with greater risk of developing dementia. 

A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current standard of care.  The new findings were released today at Heart Rhythm 2013,the Heart Rhythm Society’s 34th Annual Scientific Sessions.

The Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA) and Asia Pacific Heart Rhythm Society (APHRS), release the HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes. The expert consensus statement presented today at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions, provides the first comprehensive statement of recommendations on the proper diagnosis and management of patients with inherited primary arrhythmia syndromes.

Hugh Calkins, MD, FHRS, CCDS, was named the president of the Heart Rhythm Society (HRS) during the 34th Annual Scientific Sessions, held in Denver last week.  Announced during the Presidents’ Reception on Friday, May 10th, Dr. Calkins now serves as the 35th president of HRS, making Anne M. Gillis, MD, FHRS, the immediate past president. Dr. Calkins is currently a Nicholas J. Fortuin Professor of Medicine and Professor of Cardiology at the Johns Hopkins University of Medicine in Baltimore, Maryland.